PRESS RELEASE published on 08/14/2024 at 18:11, 1 month 5 days ago Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces purchase of own shares as part of share buyback program. Details of shares bought and voting rights disclosed Voting Rights London Stock Exchange Share Buyback Program Fuller, Smith & Turner PLC Treasury Shares
BRIEF published on 08/13/2024 at 18:14, 1 month 6 days ago Fuller, Smith & Turner PLC annonce un rachat d'actions Actions Propres Rachat D'actions Droit De Vote Bourse De Londres Fuller
BRIEF published on 08/13/2024 at 18:14, 1 month 6 days ago Fuller, Smith & Turner PLC Announces Share Buyback Voting Rights London Stock Exchange Share Buyback Treasury Shares Fuller’s
PRESS RELEASE published on 08/13/2024 at 18:09, 1 month 6 days ago Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces the purchase of 3,816 'A' ordinary shares in its share buyback programme on 13/08/2024. Shares will be held in Treasury. Details in the announcement London Stock Exchange Treasury Share Buyback Programme Fuller Smith Turner PLC 'A' Ordinary Shares
BRIEF published on 08/09/2024 at 18:07, 1 month 10 days ago Fuller, Smith & Turner PLC: Transaction in Own Shares London Stock Exchange Share Buyback Treasury Shares Fuller, Smith & Turner 2024 Transaction
BRIEF published on 08/09/2024 at 18:07, 1 month 10 days ago Fuller, Smith & Turner PLC : transaction sur actions propres Actions Propres Rachat D'actions Bourse De Londres Fuller, Smith Et Turner Transaction 2024
PRESS RELEASE published on 08/09/2024 at 18:02, 1 month 10 days ago Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces purchase of own shares as part of share buyback program, holding 4,538,411 'A' ordinary shares in treasury. Total voting rights now at 36,143,928 Voting Rights London Stock Exchange Share Buyback Program Treasury Shares Fuller Smith Turner PLC
BRIEF published on 08/06/2024 at 18:30, 1 month 13 days ago Fuller, Smith & Turner PLC: Transaction in Own Shares London Stock Exchange Ordinary Shares Share Buyback Disclosure Fuller, Smith & Turner
BRIEF published on 08/06/2024 at 18:30, 1 month 13 days ago Fuller, Smith & Turner PLC : Transaction sur actions propres Rachat D'actions Actions Ordinaires Bourse De Londres Divulgation Fuller, Smith Et Turner
PRESS RELEASE published on 08/06/2024 at 18:25, 1 month 13 days ago Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces the purchase of 20,000 'A' ordinary shares at an average price of 694.5402 pence per share as part of the share buyback program London Stock Exchange Share Buyback Program Numis Securities Limited Fuller Smith Turner PLC Share Purchase
Published on 09/20/2024 at 13:00, 34 minutes ago Aston Bay and American West Metals Thick High-Grade Copper in Deep Drilling at the Storm Project, Nunavut, Canada
Published on 09/20/2024 at 09:05, 4 hours 29 minutes ago Nano One Closes on $5 Million Sale of Vacant Land
Published on 09/20/2024 at 02:00, 11 hours 34 minutes ago Academy of Math and Science Celebrates Hispanic Heritage Month
Published on 09/19/2024 at 23:15, 14 hours 19 minutes ago Cypher Metaverse Inc. Announces Second Closing of Financing
Published on 09/20/2024 at 13:00, 34 minutes ago Le salon de l’eau, de l’énergie, de la technologie et de l’environnement (WETEX) 2024 présente les tendances d’avant-garde en matière de santé et de sécurité à domicile et sur le lieu de travail
Published on 09/20/2024 at 11:44, 1 hour 50 minutes ago Halfords Group PLC: Director/PDMR Shareholding
Published on 09/20/2024 at 11:20, 2 hours 14 minutes ago Dalata Hotel Group PLC: HOL-Holding(s) in Company*
Published on 09/20/2024 at 11:14, 2 hours 19 minutes ago EQS-Adhoc: Raiffeisen Bank International AG: RBI signs agreement on the sale of Priorbank JSC to Soven 1 Holding Limited
Published on 09/20/2024 at 08:45, 4 hours 49 minutes ago BAIKOWSKI : Rapport financier semestriel 2024
Published on 09/20/2024 at 08:00, 5 hours 34 minutes ago MEDESIS PHARMA : Résultats encourageants de la première phase de l’essai clinique de phase 2a pour le traitement de la maladie d’Alzheimer avec le NanoLIthium